These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 35431374)
1. Charge-transfer chemistry of two corticosteroids used adjunctively to treat COVID-19. Part I: Complexation of hydrocortisone and dexamethasone donors with DDQ acceptor in five organic solvents. Adam AMA; Saad HA; Refat MS; Hegab MS J Mol Liq; 2022 Jul; 357():119092. PubMed ID: 35431374 [TBL] [Abstract][Full Text] [Related]
2. Charge-transfer chemistry of two corticosteroids used adjunctively to treat COVID-19. Part II: The CT reaction of hydrocortisone and dexamethasone donors with TCNQ and fluoranil acceptors in five organic solvents. Refat MS; Albogami B; Adam AMA; Saad HA; Alsuhaibani AM; Miyan L; Hegab MS J Mol Liq; 2022 Oct; 363():119878. PubMed ID: 35880006 [TBL] [Abstract][Full Text] [Related]
3. Charge-transfer chemistry of azithromycin, the antibiotic used worldwide to treat the coronavirus disease (COVID-19). Part III: A green protocol for facile synthesis of complexes with TCNQ, DDQ, and TFQ acceptors. Adam AMA; Saad HA; Alsuhaibani AM; Refat MS; Hegab MS J Mol Liq; 2021 Aug; 335():116250. PubMed ID: 33903781 [TBL] [Abstract][Full Text] [Related]
4. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336 [TBL] [Abstract][Full Text] [Related]
5. Charge-transfer chemistry of azithromycin, the antibiotic used worldwide to treat the coronavirus disease (COVID-19). Part I: Complexation with iodine in different solvents. Adam AMA; Saad HA; Alsuhaibani AM; Refat MS; Hegab MS J Mol Liq; 2021 Mar; 325():115187. PubMed ID: 33390633 [TBL] [Abstract][Full Text] [Related]
6. Adverse Effects of Pfizer (BioNTech), Oxford-AstraZeneca (ChAdOx1 CoV-19), and Moderna COVID-19 Vaccines among the Adult Population in Saudi Arabia: A Cross-Sectional Study. Aldali J; Meo SA; Al-Khlaiwi T Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851109 [TBL] [Abstract][Full Text] [Related]
7. Charge-transfer complexation of TCNE with azithromycin, the antibiotic used worldwide to treat the coronavirus disease (COVID-19). Part IV: A comparison between solid and liquid interactions. Adam AMA; Refat MS; Altalhi TA; Alsuhaibani KS J Mol Liq; 2021 Oct; 340():117224. PubMed ID: 34393305 [TBL] [Abstract][Full Text] [Related]
8. The Safety and Effectiveness of mRNA Vaccines Against SARS-CoV-2. Jamous YF; Alhomoud DA Cureus; 2023 Sep; 15(9):e45602. PubMed ID: 37868494 [TBL] [Abstract][Full Text] [Related]
9. Recent Antiviral Treatment and Vaccination Strategies Against SARS-CoV-2. Bormann M; van de Sand L; Witzke O; Krawczyk A Klin Monbl Augenheilkd; 2021 May; 238(5):569-578. PubMed ID: 34020485 [TBL] [Abstract][Full Text] [Related]
10. Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARSCoV- 2 Infection. Costanzo M; De Giglio MAR; Roviello GN Curr Med Chem; 2022; 29(1):4-18. PubMed ID: 34355678 [TBL] [Abstract][Full Text] [Related]
11. Potential therapeutic use of corticosteroids as SARS CoV-2 main protease inhibitors: a computational study. Ghosh R; Chakraborty A; Biswas A; Chowdhuri S J Biomol Struct Dyn; 2022 Mar; 40(5):2053-2066. PubMed ID: 33094701 [TBL] [Abstract][Full Text] [Related]
12. Multiple and sequential charge transfer interactions occurring in situ: A redox reaction of thiazolidine-2-thione with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone. Rabie UM; Abou-El-Wafa MH; Nassar H Spectrochim Acta A Mol Biomol Spectrosc; 2011 Sep; 79(5):1411-7. PubMed ID: 21680233 [TBL] [Abstract][Full Text] [Related]
13. Exploring the adverse events of Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, and Johnson and Johnson COVID-19 vaccination on Guillain-Barré Syndrome. Meo SA; Shaikh N; Abukhalaf FA; Meo AS Sci Rep; 2024 Aug; 14(1):18767. PubMed ID: 39138276 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study). Vokó Z; Kiss Z; Surján G; Surján O; Barcza Z; Wittmann I; Molnár GA; Nagy D; Müller V; Bogos K; Nagy P; Kenessey I; Wéber A; Polivka L; Pálosi M; Szlávik J; Rokszin G; Müller C; Szekanecz Z; Kásler M Front Immunol; 2022; 13():919408. PubMed ID: 35935993 [TBL] [Abstract][Full Text] [Related]
16. A Case of Acute Pulmonary Embolus after mRNA SARS-CoV-2 Immunization. Wiest NE; Johns GS; Edwards E Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34452028 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular Complications of SARS-CoV-2 Vaccines: An Overview. Shiravi AA; Ardekani A; Sheikhbahaei E; Heshmat-Ghahdarijani K Cardiol Ther; 2022 Mar; 11(1):13-21. PubMed ID: 34845662 [TBL] [Abstract][Full Text] [Related]
18. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia. Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883 [TBL] [Abstract][Full Text] [Related]